Welcome > Support > Âü°íÀÚ·á  
 
 
E
 
±Ûº¸±â
¼º¸í ÆÄ³ªÁø     (Date : 2010-12-21 15:52:50)
Á¦¸ñ [³í¹®] [PNA Chip vs DNA Chip ÀÓ»ó½ÇÇè ³í¹®]
³»¿ë

ÇöÀç »ç¾÷ ÁßÀÎ PANArray¢â HPV Genotyping Chip°ú DNA ChipÀÇ ºñ±³ ³í¹®ÀÌ ¾Æ·¡¿Í °°ÀÌ  BioChip journal¿¡ °ÔÀçµÇ¾ú½À´Ï´Ù.


Á¦¸ñ :
Comparison of the performance of the PANArray¢â HPV test and DNA chip test for genotyping of human papillomavirus in cervical swabs

ÀúÀÚ :
Hye Jong Song, Jeong Won Lee, Byoung Gie Kim, Sang Yong Song, Duk Soo Bae & Dae Shick Kim

Ãâó :
Received: 5 March 2010 / Accepted: 20 May 2010 / Published online: 20 September 2010
􀋄 The Korean BioChip Society and Springer 2010

¹ßÇ࿬µµ : 2010

ÁÖÁ¦Å°¿öµå : PNA, PNA microarray, Human papillomavirus(HPV), HPV genotyping


ÃÊ·Ï(¿µ¹®) :
The aim of this study was to evaluate the recently developed PANArrayTM Human papilloma virus (HPV) kit for detection and genotyping of 19 high-risk and 13 low-risk HPV types, and compare it with the commercially available DNA chip kit genotyping of 24 HPVs. We collected cervical swabs from 741 patients with various stages of invasive cervical
carcinoma being treated at the Samsung Medical Center. The overall HPV positivity rate was 73% using PANArrayTM HPV and 72.1% with the DNA chip, and no statistically significant differences were found with respect to the cytology grade. Comparing the results of the two chips, concordant results were found in 637/741 samples (85.9%), compatible in 69/741(9.3%) and discordant in 35/741 (4.7%). Type-specific sequencing analysis of all samples revealed a 99.7% confirmation of PANArrayTM HPV genotyping results, compared to 91.0% of DNA chip. The PANArrayTM HPV test thus proved to be highly sensitive and accurate even when multiple HPV infections were present.

* ÀÚ¼¼ÇÑ »çÇ×Àº ÷ºÎÆÄÀÏ ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.

* ¸µÅ©´Â ¿©±âÀÔ´Ï´Ù.


 

 ¹øÈ£   Á¦¸ñ ÀÛ¼ºÀÚ ÆÄÀÏ Á¶È¸
   49           [³í¹®] [2016]Comparison of EGFR .. ÆÄ³ªÁø 30627
   48           [³í¹®] [2015]IDH Mutation Analys.. ÆÄ³ªÁø 65535
   47           [³í¹®] [2015]Low frequency of KR.. ÆÄ³ªÁø 41433
   46           [³í¹®] [2015]Simultaneous genoty.. ÆÄ³ªÁø 6448
   45           [³í¹®] [2014]Simultaneous diagno.. ÆÄ³ªÁø 25262
   44           [³í¹®] [2014]KRAS Mutation Detec.. ÆÄ³ªÁø 11211
   43           [³í¹®] [2013]Detection of EGFR m.. ÆÄ³ªÁø 1448
   42           [³í¹®] [2013]Detection and compa.. ÆÄ³ªÁø 6080
   41           [³í¹®] [2013]Detection of BRAF V.. ÆÄ³ªÁø 6432
   40           [³í¹®] [2013]Comparison of Direc.. ÆÄ³ªÁø 29521
   39           [³í¹®] [Microarray]Peptide nucle.. ÆÄ³ªÁø 17185
   38           [³í¹®] [Clamp]Rapid and Sensitiv.. ÆÄ³ªÁø 35177
   37           [³í¹®] [ÆÄ³ªÁø Á¦Ç°»ç¿ë ³í¹®] EGFR µ¹¿¬º¯.. ÆÄ³ªÁø 3705
   36           [³í¹®] [ÆÄ³ªÁø Á¦Ç°»ç¿ë ³í¹®] Development .. ÆÄ³ªÁø 17372
   35           [³í¹®] [ÆÄ³ªÁø Á¦Ç°»ç¿ë ³í¹®] JHDM3A modul.. ÆÄ³ªÁø 1492
¢º           [³í¹®] [PNA Chip vs DNA Chip ÀÓ»ó.. ÆÄ³ªÁø 8980
   33           [³í¹®] [ÆÄ³ªÁø ³í¹®¹ßÇ¥] PNA-mediated Re.. ÆÄ³ªÁø 14818
   32           [³í¹®] [ÆÄ³ªÁø Á¦Ç°»ç¿ë ³í¹®] ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡.. ÆÄ³ªÁø 18471
   31           [³í¹®] [ÆÄ³ªÁø ³í¹® ¹ßÇ¥] PNA-Based Anti.. ÆÄ³ªÁø 3989
   30           [³í¹®] [ÆÄ³ªÁø ³í¹®¹ßÇ¥]Peptide nucleic .. ÆÄ³ªÁø 4240
 

< 1 2 3 >